2m 2m 2m 2m 2m 2m 2m
Supernus Pharm (SUPN)
NASDAQ
$42.39+$0.20 (+0.49%)
Price as of Oct 02, 2026 5:49 PM EDT- $2.5BMarket Cap
- -12.05%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Supernus Pharm (SUPN)
$42.39+$0.20 (+0.49%)
Earnings Score
Valuation | SUPN | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | SUPN | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -5.96% | ||
12-Month Momentum | -8.95% | ||
3-Month Risk Adjusted Momentum | -36.66% | ||
12-Month Risk Adjusted Momentum | -25.53% |
True Yield
Valuation | SUPN | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | SUPN | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 7 |